Related Experiment Video
Updated: Jun 22, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
Silencing of ErbB3/ErbB2 signaling by immunoglobulin-like Necl-2
Satoshi Kawano1, Wataru Ikeda, Megumi Kishimoto
1Division of Molecular and Cellular Biology, Department of Biochemistry, Kobe University Graduate School of Medicine, Kobe 650-0017, Hyogo, Japan.
Abstract:
ErbB2 and ErbB3, members of the EGF receptor/ErbB family, form a heterodimer upon binding of a ligand, inducing the activation of Rac small G protein and Akt protein kinase for cell movement and survival, respectively. The enhanced ErbB3/ErbB2 signaling causes tumorigenesis, invasion, and metastasis. We found here that the ErbB3/ErbB2 signaling is regulated by immunoglobulin-like Necl-2, which is down-regulated in various cancer cells and serves as a tumor suppressor. The extracellular region of ErbB3, but not ErbB2, interacted in cis with that of Necl-2. This interaction reduced the ligand-induced, ErbB2-catalyzed tyrosine phosphorylation of ErbB3 and inhibited the consequent ErbB3-mediated activation of Rac and Akt, resulting in the inhibition of cancer cell movement and survival. These inhibitory effects of Necl-2 were mediated by the protein-tyrosine phosphatase PTPN13 which interacted with the cytoplasmic tail of Necl-2. We describe here this novel mechanism for silencing of the ErbB3/ErbB2 signaling by Necl-2.
Insights
Necl-2 acts as a tumor suppressor by inhibiting ErbB3/ErbB2 signaling. This interaction reduces cancer cell movement and survival, offering a novel therapeutic target for cancer.
Area of Science:
- Cell Biology
- Molecular Oncology
- Cancer Research
Background:
- ErbB2 and ErbB3 signaling pathways are crucial for cell movement and survival.
- Aberrant ErbB3/ErbB2 signaling drives tumorigenesis, invasion, and metastasis.
- Necl-2, an immunoglobulin-like molecule, is downregulated in cancer and acts as a tumor suppressor.
Purpose of the Study:
- To elucidate the mechanism by which Necl-2 regulates ErbB3/ErbB2 signaling.
- To investigate the role of Necl-2 in controlling cancer cell proliferation, movement, and survival.
Main Methods:
- Investigated the interaction between Necl-2 and ErbB3/ErbB2 receptors.
- Analyzed the effect of Necl-2 on ligand-induced tyrosine phosphorylation of ErbB3.
- Examined the impact of Necl-2 on Rac and Akt activation.
- Identified the role of protein-tyrosine phosphatase PTPN13 in mediating Necl-2's effects.
Main Results:
- Necl-2 directly interacts with the extracellular region of ErbB3, not ErbB2.
- This interaction inhibits ErbB2-catalyzed tyrosine phosphorylation of ErbB3.
- Necl-2 suppresses ErbB3-mediated activation of Rac and Akt, inhibiting cancer cell movement and survival.
- The tumor-suppressive effects of Necl-2 are mediated by PTPN13 binding to its cytoplasmic tail.
Conclusions:
- Necl-2 functions as a tumor suppressor by inhibiting ErbB3/ErbB2 signaling through a novel mechanism.
- This pathway involves direct interaction with ErbB3 and recruitment of PTPN13.
- Targeting the Necl-2-mediated silencing of ErbB3/ErbB2 signaling represents a potential therapeutic strategy for various cancers.
Related Concept Videos
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Mitogens and the Cell Cycle
Hedgehog Signaling Pathway
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...